BCL2L11 and lung carcinoma: Furthermore, a recent Japanese study has highlighted a correlation between the BIM deletion and relapse-free survival in patients with early-stage resected lung cancer [49], suggesting possible implications of the BIM deletion on adjuvant therapy in early-stage lung cancer, where vinorelbine is widely used.